Trevi Therapeutics Inc
TRVI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.63B
Close$
$0.13
99.3% downside
Current Fair Value
99.3% downsideOvervalued by 99.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.63 Billion |
|---|---|
| Enterprise Value | $2.57 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 1 |
| Outstanding Shares | 156,602,158 |
Return
| Return on Equity | -15.90% |
|---|---|
| Return on Assets | -15.46% |
| Return on Invested Capital | -17.69% |
Valuation & Multiples
| P/E Ratio | -54.8 |
|---|---|
| PEG | -122.64 |
| Price to Sales | - |
| Price to Book Ratio | 9.08 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -45.21 |
| Enterprise Value to Net Income | -51 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.13
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 31.57% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 17.97%▼ 74.76% |
|---|---|
| Total Invested | $487.91M▼ 69.79% |
| Investors Holding | 70▼ 135.00% |
ESG Score
No data